Imris Inc (IMRS) 1.04 $IMRS
Market Maker Surveillance Report. COUP, PEGFF, RCON, WPRT, IMRS, MDBX, Losing Stocks With Lowest Price Friction For Tuesday, February 10th 2015
M2 - Wed Feb 11, 2:57AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5332 companies with "abnormal" market making, 3306 companies with positive Friction Factors and 2888 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. COMPUCOMP CORP (NYSE:COUP), PACIFIC RUBIALES ENERGY CORP (OTC
EGFF), Recon Technology Ltd (NASDAQ:RCON), WESTPORT INNOVATIONS INC (NASDAQ:WPRT), IMRIS INC (NASDAQ:IMRS), (OTC:MDBX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net .
WPRT: 6.06 (+0.26), COUP: 11.06 (-0.07), IMRS: 1.04 (-0.03), RCON: 2.11 (+0.15)
Short Sellers Eye Genetic Tech
Interactive Brokers - Seeking Alpha - Tue Feb 10, 1:58PM CST
Following the recent increase in its share price, Genetic Tech Ltd. (NASDAQ: GENE ) was a highly sought-after short-borrow request. Limited availability pushed the cost to borrow up substantially while demand remains strong. Shares in GENE spiked...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), SHAK: 40.69 (+0.04), DDD: 32.81 (+0.40), BBEP: 7.85 (+0.32), SN: 15.21 (-0.12), YOD: 2.22 (+0.04), MNKD: 7.00 (+0.02), MCP: 0.97 (+0.04), GENE: 8.04 (+1.90), BTU: 7.65 (+0.46), IMRS: 1.04 (-0.03), PSTR: 4.63 (+0.14), LINE: 12.94 (+0.40)
Siemens Healthcare and IMRIS Join Together to Bring Unique Hybrid ORs to Sahlgrenska University Hospital in Sweden
PR Newswire Europe - Tue Jan 20, 7:12AM CST
MINNEAPOLIS, Minnesota, January 20, 2015 /PRNewswire/ --
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Siemens Healthcare and IMRIS join together to bring unique hybrid ORs to Sahlgrenska University Hospital in Sweden
PR Newswire - Tue Jan 20, 7:01AM CST
VISIUS Surgical Theatre with intraoperative MRI included in first of its kind Northern Europe installation
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Securities Lending Notable Names: JCP, AMBA
Interactive Brokers - at Seeking Alpha - Tue Jan 13, 2:32AM CST
Strong sales guidance gave some life to struggling department store operator, J.C. Penney Co., Inc. (NYSE: JCP ) last week following a prolonged period of negative news. The stock soared approximately 17% on Tuesday of last week after the company...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), EDAP: 3.55 (+0.13), LNCO: 12.30 (+0.28), IMRS: 1.04 (-0.03), GALT: 3.84 (+0.16), JCP: 8.05 (+0.14), MOC: 2.24 (+0.02), BIND: 6.06 (+0.21), LINE: 12.94 (+0.40), JOB: 0.79 (+0.01), BCLI: 3.86 (-0.02), NDRM: 10.76 (+0.22)
Nasdaq stocks posting largest volume increases
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SIBC: 21.10 (+0.22), IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07), HFFC: 14.82 (+0.29), TGLS: 9.89 (+0.09), REMY: 22.59 (-0.22)
Imris capital raise breathes fresh air into shares
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 12:50PM CST
IMRS: 1.04 (-0.03)
Centara Corp. Acquires Securities of IMRIS Inc.
CNW Group - Wed Dec 24, 1:42PM CST
Centara Corp. ("Centara"
announces that it purchased an aggregate of 2,376,760 units (the "Units" on a private placement basis (the "Offering" from IMRIS Inc. ("IMRIS" or the "Company" pursuant to the terms of a subscription agreement (the "Subscription Agreement" . Each Unit was purchased at a price of $0.284 per Unit and consists of one common share of the Company (a "Common Share" and one and a quarter Common Share purchase warrant (each whole warrant, a "Warrant" . Each whole Warrant entitles the holder thereof to acquire one Common Share at a price of $03692 per share during the period starting on the day that is six months from the date of issue and ending on the day that is five and a half years from the date of issue. In connection with the Offering, Centara purchased an aggregate of 2,376,760 Units, which are comprised of 2,376,760 Common Shares and 2,970,950 Warrants. Upon exercise of the Warrants in full, Centara would acquire 2,970,950 Common Shares.
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
IMRIS Announces Closing of Private Placement Offering of Units
PR Newswire - Wed Dec 24, 10:57AM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company" today announced it has closed the private placement offering of 10,563,380 units at an offering price of US$0.284 per unit. Each unit (the "Units" consists of one common share of the Company (the "Common Shares" and one and a quarter common share purchase warrants (the "Warrants" . Each whole Warrant is exercisable into one Common Share during the period starting on the day that is four months from the date of issue and ending on the day that is five and a half years from the date of issue at an exercise price per common share of US$0.3692. The gross proceeds to IMRIS in connection with the offering are US$3.0 million.
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
IMRIS Announces Private Placement Offering of Units and Other Corporate Developments
CNW Group - Mon Dec 22, 5:23PM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company" today announced a private placement offering of 10,563,380 units at an offering price of US$0.284 per unit (the "Offering" . Each unit (the "Units" consists of one common share of the Company (the "Common Shares" and one and a quarter common share purchase warrants (the "Warrants" . Each whole Warrant is exercisable into one Common Share during the period starting on the day that is four months from the date of issue and ending on the day that is five and a half years from the date of issue at an exercise price per common share of US$0.3692. The gross proceeds to IMRIS will be approximately US$3.0 million.
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Global Intraoperative Imaging Report - Micro Market Monitor 2014-2019
M2 - Wed Dec 17, 5:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/8t8qwk/micro_market) has announced the addition of the "Micro Market Monitor: Global Intraoperative Imaging Market" report to their offering. The global intraoperative imaging market is estimated to grow at a CAGR of 3.5% from 2014 to 2019 The demand for high-end automated imaging devices is on the rise and is moving in tandem with the increasing need of highly sophisticated imaging technologies, which can offer reliable and quick results. However, factors such as varied stringency of regulatory procedures across the globe and patient safety concerns are expected to restrain the growth of this market in the coming years. Moreover, an excise tax of 2.3% is being levied on medical devices in the U.S. This is expected to hinder the growth of this market to some extent. An increase in the number of collaborations among different market players and automation in cancer research for early cancer detection provide opportunities for advancements in this market. In this report, the global intraoperative imaging market is broadly classified on the basis of product types. The products segment is classified into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Furthermore, based on type, the intraoperative CT market has been segmented further into mobile intraoperative CT, fully intraoperative suites, and O-arms and similar products. Geographically, the market is divided into four major regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds a major share in the global intraoperative imaging market, having accounted for 63.6% of the market in 2013, followed by Europe. The growth of the North American market is expected to be driven by factors such as the increasing government investments, research activities, and growing number of collaborations between various players in the market. Key Topics Covered: 1 Executive Summary 2 Market Overview 3 Global Intraoperative Imaging Market 4 Intraoperative Imaging Market, By Segments 5 Competitive Landscape 6 Company Profiles - Brainlab Ag - Imris Inc. - Medtronic, Inc. - Neurologica Corporation ( Subsidiary Of Samsung Electronics) - Philips Healthcare (A Subsidiary Of Royal Philips Electronics) - Siemens Healthcare (Subsidiary Of Siemens Ag) For more information visit http://www.researchandmarkets.com/research/8t...cro_market
PHG: 28.93 (-0.07), MDT: 75.26 (+0.33), IMRS: 1.04 (-0.03)
Micro Market Monitor: Global Hyperspectral Imaging Market
M2 - Fri Dec 12, 4:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/kdmfrn/micro_market) has announced the addition of the "Micro Market Monitor: Global Hyperspectral Imaging Market" report to their offering. In this report, the global intraoperative imaging market is broadly classified on the basis of product types. The products segment is classified into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Furthermore, based on type, the intraoperative CT market has been segmented further into mobile intraoperative CT, fully intraoperative suites, and O-arms and similar products. Geographically, the market is divided into four major regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds a major share in the global intraoperative imaging market, having accounted for 63.6% of the market in 2013, followed by Europe. The growth of the North American market is expected to be driven by factors such as the increasing government investments, research activities, and growing number of collaborations between various players in the market. The report has profiled the leading players of this market along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years, and the strategies adopted by them to sustain and strengthen their position in the global intraoperative imaging market. BrainLAB AG (Germany), IMRIS Inc. (U.S.), Imaging3 Inc., (U.S.), Medtronic Inc., (U.S.), Neurologica Corporation (U.S.), and Siemens Healthcare (U.S.) are some of the key players engaged in this market. Key Topics Covered: 1 Hyperspectral Imaging Market, By Application 2 Hyperspectral Imaging Market, By Application 3 Global Hyperspectral Imaging Market, By Geography 4 Competitive Landscape Companies Mentioned - Applied Spectral Imaging Ltd. (U.S.) - Brandywine Photonics LLC (U.S.) - ChemImage Corp. (U.S.) - Cubert-GmbH (Germany) - CytoViva - FluxData - Galileo Group - GeoMetWatch Corp. (U.S.) - Gilden Photonics Ltd. (U.K.) - Gooch & Housego (U.K.) - Headwall Photonics Inc. (U.S.) - HyVista Corporation Pty Ltd (Australia) - IMEC (Belgium) - ITRES (Canada) - Inc. (U.S.) - Inno-spec GmbH (Germany) - LemnaTec GmbH (Germany) - Merrick & Company (U.S.) - MicaSense - Middleton Research (U.S.) - Raytheon ELCAN optical technologies (Canada) - Resonon - SPECIM (Finland) - Scientific Aerial Imaging - SpecTIR (U.S.) - Surface Optics Corp. (U.S.) - Teledyne DALSA Inc. (Canada) - VK DI Kerschhaggl GmbH (Germany) - Telops (Canada) For more information visit http://www.researchandmarkets.com/research/kd...cro_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MDT: 75.26 (+0.33), RTN: 107.03 (-0.37), IMRS: 1.04 (-0.03)
5 Under-$10 Stocks Setting Up to Trade Higher: Must-See Charts
at The Street - Fri Dec 05, 10:21AM CST
Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
CRNT: 1.02 (+0.01), AMKR: 8.90 (-0.02), IMRS: 1.04 (-0.03), NTLS: 5.19 (+0.05), BSDM: 0.39 (+0.01)
IMRIS completes SYMBIS Surgical System human factors study
PR Newswire - Mon Dec 01, 5:12AM CST
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
PR Newswire - Mon Nov 17, 3:53PM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum at the Westin Grand Central, New York at 8:40 a.m. Eastern Time on Thursday, November 20, 2014.
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Market Maker Surveillance Report. COUP, PEGFF, RCON, WPRT, IMRS, MDBX, Losing Stocks With Lowest Price Friction For Tuesday, February 10th 2015
M2 - Wed Feb 11, 2:57AM CST
BUYINS.NET / www.buyins.net, announced today its proprietary Market Maker Friction Factor Report for Tuesday. Since October 2008 market makers are now required to be on the bid as much as they are on the offer and for like amounts of stock. This Fair Market Making Requirement is designed to prevent market makers from manipulating stock prices. On Tuesday there were 5332 companies with "abnormal" market making, 3306 companies with positive Friction Factors and 2888 companies with negative Friction Factors. Here is a list of the top companies with the largest percentage loss per share Tuesday and low price friction (bearish). This means that there was more selling than buying in the stocks and their stock prices dropped faster with less Friction. COMPUCOMP CORP (NYSE:COUP), PACIFIC RUBIALES ENERGY CORP (OTC
EGFF), Recon Technology Ltd (NASDAQ:RCON), WESTPORT INNOVATIONS INC (NASDAQ:WPRT), IMRIS INC (NASDAQ:IMRS), (OTC:MDBX). To access Friction Factor, Naked Short Data and SqueezeTrigger Prices on all stocks please visit http://www.buyins.net . WPRT: 6.06 (+0.26), COUP: 11.06 (-0.07), IMRS: 1.04 (-0.03), RCON: 2.11 (+0.15)
Short Sellers Eye Genetic Tech
Interactive Brokers - Seeking Alpha - Tue Feb 10, 1:58PM CST
Following the recent increase in its share price, Genetic Tech Ltd. (NASDAQ: GENE ) was a highly sought-after short-borrow request. Limited availability pushed the cost to borrow up substantially while demand remains strong. Shares in GENE spiked...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), SHAK: 40.69 (+0.04), DDD: 32.81 (+0.40), BBEP: 7.85 (+0.32), SN: 15.21 (-0.12), YOD: 2.22 (+0.04), MNKD: 7.00 (+0.02), MCP: 0.97 (+0.04), GENE: 8.04 (+1.90), BTU: 7.65 (+0.46), IMRS: 1.04 (-0.03), PSTR: 4.63 (+0.14), LINE: 12.94 (+0.40)
Siemens Healthcare and IMRIS Join Together to Bring Unique Hybrid ORs to Sahlgrenska University Hospital in Sweden
PR Newswire Europe - Tue Jan 20, 7:12AM CST
MINNEAPOLIS, Minnesota, January 20, 2015 /PRNewswire/ --
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Siemens Healthcare and IMRIS join together to bring unique hybrid ORs to Sahlgrenska University Hospital in Sweden
PR Newswire - Tue Jan 20, 7:01AM CST
VISIUS Surgical Theatre with intraoperative MRI included in first of its kind Northern Europe installation
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Securities Lending Notable Names: JCP, AMBA
Interactive Brokers - at Seeking Alpha - Tue Jan 13, 2:32AM CST
Strong sales guidance gave some life to struggling department store operator, J.C. Penney Co., Inc. (NYSE: JCP ) last week following a prolonged period of negative news. The stock soared approximately 17% on Tuesday of last week after the company...
AMBA: 50.71 (-4.46), GPRO: 45.27 (-0.02), EDAP: 3.55 (+0.13), LNCO: 12.30 (+0.28), IMRS: 1.04 (-0.03), GALT: 3.84 (+0.16), JCP: 8.05 (+0.14), MOC: 2.24 (+0.02), BIND: 6.06 (+0.21), LINE: 12.94 (+0.40), JOB: 0.79 (+0.01), BCLI: 3.86 (-0.02), NDRM: 10.76 (+0.22)
Nasdaq stocks posting largest volume increases
AP - Wed Dec 31, 6:59PM CST
NEW YORK (AP) — A look at the 10 biggest volume gainers on Nasdaq at the close of trading:
SIBC: 21.10 (+0.22), IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07), HFFC: 14.82 (+0.29), TGLS: 9.89 (+0.09), REMY: 22.59 (-0.22)
Imris capital raise breathes fresh air into shares
Seeking Alpha - at Seeking Alpha - Wed Dec 31, 12:50PM CST
IMRS: 1.04 (-0.03)
Centara Corp. Acquires Securities of IMRIS Inc.
CNW Group - Wed Dec 24, 1:42PM CST
Centara Corp. ("Centara"
announces that it purchased an aggregate of 2,376,760 units (the "Units" on a private placement basis (the "Offering" from IMRIS Inc. ("IMRIS" or the "Company" pursuant to the terms of a subscription agreement (the "Subscription Agreement" . Each Unit was purchased at a price of $0.284 per Unit and consists of one common share of the Company (a "Common Share" and one and a quarter Common Share purchase warrant (each whole warrant, a "Warrant" . Each whole Warrant entitles the holder thereof to acquire one Common Share at a price of $03692 per share during the period starting on the day that is six months from the date of issue and ending on the day that is five and a half years from the date of issue. In connection with the Offering, Centara purchased an aggregate of 2,376,760 Units, which are comprised of 2,376,760 Common Shares and 2,970,950 Warrants. Upon exercise of the Warrants in full, Centara would acquire 2,970,950 Common Shares. IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
IMRIS Announces Closing of Private Placement Offering of Units
PR Newswire - Wed Dec 24, 10:57AM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company"
today announced it has closed the private placement offering of 10,563,380 units at an offering price of US$0.284 per unit. Each unit (the "Units" consists of one common share of the Company (the "Common Shares" and one and a quarter common share purchase warrants (the "Warrants" . Each whole Warrant is exercisable into one Common Share during the period starting on the day that is four months from the date of issue and ending on the day that is five and a half years from the date of issue at an exercise price per common share of US$0.3692. The gross proceeds to IMRIS in connection with the offering are US$3.0 million. IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
IMRIS Announces Private Placement Offering of Units and Other Corporate Developments
CNW Group - Mon Dec 22, 5:23PM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) ("IMRIS" or the "Company"
today announced a private placement offering of 10,563,380 units at an offering price of US$0.284 per unit (the "Offering" . Each unit (the "Units" consists of one common share of the Company (the "Common Shares" and one and a quarter common share purchase warrants (the "Warrants" . Each whole Warrant is exercisable into one Common Share during the period starting on the day that is four months from the date of issue and ending on the day that is five and a half years from the date of issue at an exercise price per common share of US$0.3692. The gross proceeds to IMRIS will be approximately US$3.0 million. IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
Global Intraoperative Imaging Report - Micro Market Monitor 2014-2019
M2 - Wed Dec 17, 5:26AM CST
Research and Markets (http://www.researchandmarkets.com/research/8t8qwk/micro_market) has announced the addition of the "Micro Market Monitor: Global Intraoperative Imaging Market" report to their offering. The global intraoperative imaging market is estimated to grow at a CAGR of 3.5% from 2014 to 2019 The demand for high-end automated imaging devices is on the rise and is moving in tandem with the increasing need of highly sophisticated imaging technologies, which can offer reliable and quick results. However, factors such as varied stringency of regulatory procedures across the globe and patient safety concerns are expected to restrain the growth of this market in the coming years. Moreover, an excise tax of 2.3% is being levied on medical devices in the U.S. This is expected to hinder the growth of this market to some extent. An increase in the number of collaborations among different market players and automation in cancer research for early cancer detection provide opportunities for advancements in this market. In this report, the global intraoperative imaging market is broadly classified on the basis of product types. The products segment is classified into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Furthermore, based on type, the intraoperative CT market has been segmented further into mobile intraoperative CT, fully intraoperative suites, and O-arms and similar products. Geographically, the market is divided into four major regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds a major share in the global intraoperative imaging market, having accounted for 63.6% of the market in 2013, followed by Europe. The growth of the North American market is expected to be driven by factors such as the increasing government investments, research activities, and growing number of collaborations between various players in the market. Key Topics Covered: 1 Executive Summary 2 Market Overview 3 Global Intraoperative Imaging Market 4 Intraoperative Imaging Market, By Segments 5 Competitive Landscape 6 Company Profiles - Brainlab Ag - Imris Inc. - Medtronic, Inc. - Neurologica Corporation ( Subsidiary Of Samsung Electronics) - Philips Healthcare (A Subsidiary Of Royal Philips Electronics) - Siemens Healthcare (Subsidiary Of Siemens Ag) For more information visit http://www.researchandmarkets.com/research/8t...cro_market
PHG: 28.93 (-0.07), MDT: 75.26 (+0.33), IMRS: 1.04 (-0.03)
Micro Market Monitor: Global Hyperspectral Imaging Market
M2 - Fri Dec 12, 4:08AM CST
Research and Markets (http://www.researchandmarkets.com/research/kdmfrn/micro_market) has announced the addition of the "Micro Market Monitor: Global Hyperspectral Imaging Market" report to their offering. In this report, the global intraoperative imaging market is broadly classified on the basis of product types. The products segment is classified into intraoperative MRI, intraoperative CT, and intraoperative ultrasound. Furthermore, based on type, the intraoperative CT market has been segmented further into mobile intraoperative CT, fully intraoperative suites, and O-arms and similar products. Geographically, the market is divided into four major regions, namely North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America holds a major share in the global intraoperative imaging market, having accounted for 63.6% of the market in 2013, followed by Europe. The growth of the North American market is expected to be driven by factors such as the increasing government investments, research activities, and growing number of collaborations between various players in the market. The report has profiled the leading players of this market along with the developments (new product launches, partnerships, agreements, collaborations, and joint ventures) done by the companies over the past few years, and the strategies adopted by them to sustain and strengthen their position in the global intraoperative imaging market. BrainLAB AG (Germany), IMRIS Inc. (U.S.), Imaging3 Inc., (U.S.), Medtronic Inc., (U.S.), Neurologica Corporation (U.S.), and Siemens Healthcare (U.S.) are some of the key players engaged in this market. Key Topics Covered: 1 Hyperspectral Imaging Market, By Application 2 Hyperspectral Imaging Market, By Application 3 Global Hyperspectral Imaging Market, By Geography 4 Competitive Landscape Companies Mentioned - Applied Spectral Imaging Ltd. (U.S.) - Brandywine Photonics LLC (U.S.) - ChemImage Corp. (U.S.) - Cubert-GmbH (Germany) - CytoViva - FluxData - Galileo Group - GeoMetWatch Corp. (U.S.) - Gilden Photonics Ltd. (U.K.) - Gooch & Housego (U.K.) - Headwall Photonics Inc. (U.S.) - HyVista Corporation Pty Ltd (Australia) - IMEC (Belgium) - ITRES (Canada) - Inc. (U.S.) - Inno-spec GmbH (Germany) - LemnaTec GmbH (Germany) - Merrick & Company (U.S.) - MicaSense - Middleton Research (U.S.) - Raytheon ELCAN optical technologies (Canada) - Resonon - SPECIM (Finland) - Scientific Aerial Imaging - SpecTIR (U.S.) - Surface Optics Corp. (U.S.) - Teledyne DALSA Inc. (Canada) - VK DI Kerschhaggl GmbH (Germany) - Telops (Canada) For more information visit http://www.researchandmarkets.com/research/kd...cro_market About Research and Markets Research and Markets is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.
MDT: 75.26 (+0.33), RTN: 107.03 (-0.37), IMRS: 1.04 (-0.03)
5 Under-$10 Stocks Setting Up to Trade Higher: Must-See Charts
at The Street - Fri Dec 05, 10:21AM CST
Traders savvy enough to follow the low-priced names and trade them with discipline and sound risk management are banking ridiculous coin on a regular basis.
CRNT: 1.02 (+0.01), AMKR: 8.90 (-0.02), IMRS: 1.04 (-0.03), NTLS: 5.19 (+0.05), BSDM: 0.39 (+0.01)
IMRIS completes SYMBIS Surgical System human factors study
PR Newswire - Mon Dec 01, 5:12AM CST
18 US neurosurgeons from 9 leading institutions validate robot usability for final 510(k) submission deliverable
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
IMRIS CEO Jay D. Miller to present at the Canaccord Genuity Medical Technologies & Diagnostics Forum
PR Newswire - Mon Nov 17, 3:53PM CST
IMRIS Inc. (NASDAQ: IMRS; TSX: IM) will present at the Canaccord Genuity 2014 Medical Technologies & Diagnostics Forum at the Westin Grand Central, New York at 8:40 a.m. Eastern Time on Thursday, November 20, 2014.
IMRS: 1.04 (-0.03), IM.TO: 1.30 (-0.07)
